KMT2D expression and mutational status did not emerge as a prognostic marker for UTUC; however, KMT2D alterations and expression were associated with features of clinically aggressive UTUC such as multifocality, ureteral location, and previous bladder cancer. The gene discussed is KMT2D; the disease is urinary bladder cancer.